The global asthma treatment market is projected to reach USD 30,400 million by 2025, driven by the rising prevalence of asthma worldwide and increasing advancements in inhaler technology and biologics. With a CAGR of 5.60%, the market is expected to grow to USD 47,009.4 million by 2033. Key growth drivers include the growing adoption of personalized medicine, expanding healthcare access in emerging economies, and the development of novel biologic therapies. The increasing burden of air pollution and allergens is further fueling demand for effective long-term asthma management solutions, including inhaled corticosteroids, bronchodilators, and combination therapies.4o